Investors Asset Management Of Georgia Inc Biogen Inc. Transaction History
Investors Asset Management Of Georgia Inc
- $208 Million
- Q3 2024
A detailed history of Investors Asset Management Of Georgia Inc transactions in Biogen Inc. stock. As of the latest transaction made, Investors Asset Management Of Georgia Inc holds 1,032 shares of BIIB stock, worth $179,072. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,032
Previous 1,032
-0.0%
Holding current value
$179,072
Previous $239,000
16.32%
% of portfolio
0.1%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,018Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$2.88 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.84 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.52 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.23 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$985 Million0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $25B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...